← back to search

Kathleen R. Cho

University of Michigan · US
Area of research
Reproductive Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Genetic factors in colorectal cancer, Cervical Cancer and HPV Research, and Endometrial and Cervical Cancer Treatments.
h-index
80
citations
27,450
works
329
NIH funding
primary concept
email

Recent publications

Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Proceedings of the National Academy of Sciences 2025cited by 6position: middledoi
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Cell 2024cited by 50position: middledoi
A framework for assessing interactions for risk stratification models: the example of ovarian cancer
JNCI Journal of the National Cancer Institute 2023cited by 3position: middledoi
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
Nature Metabolism 2022cited by 35position: middledoi
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
Gynecologic Oncology 2021cited by 12position: middledoi
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
Carcinogenesis 2021cited by 11position: middledoi
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
Journal of Clinical Investigation 2020cited by 198position: middledoi
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
Gynecologic Oncology 2020cited by 28position: middledoi
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2019cited by 1,064position: middledoi
International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group
International Journal of Gynecological Pathology 2018cited by 75position: firstdoi
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis
eLife 2017cited by 100position: middledoi
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2016cited by 173position: middledoi
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Nature 2015cited by 1,173position: middledoi
Cervical Cancer, Version 2.2015
Journal of the National Comprehensive Cancer Network 2015cited by 334position: middledoi
Uterine Sarcoma, Version 1.2016
Journal of the National Comprehensive Cancer Network 2015cited by 74position: middledoi
Uterine Neoplasms, Version 1.2014
Journal of the National Comprehensive Cancer Network 2014cited by 183position: middledoi
HRAS mutations are frequent in inverted urothelial neoplasms
Human Pathology 2014cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Linda Vatan · Parker Institute for Cancer Immunotherapy2 papers (2015–2020)Yali Dou · University of Southern California2 papers (2015–2020)Shuang Wei · Hubei University of Medicine2 papers (2015–2020)Lili Zhao · Children’s Hospital of Fudan University Xiamen Branch2 papers (2015–2020)Weiping Zou · University of Michigan2 papers (2015–2020)Arul M. Chinnaiyan · BioSurfaces (United States)2 papers (2014–2020)Ilona Kryczek · Michigan Cancer Research Consortium2 papers (2015–2020)Michael D. Green · University of Pittsburgh1 papers (2020–2020)Cheryl T. Lee · The Ohio State University Wexner Medical Center1 papers (2014–2014)Michael J. Quist · Cedars-Sinai Medical Center1 papers (2014–2014)Philip P.C. Ip · Queen Mary Hospital1 papers (2018–2018)Douglas A. Levine · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Adnan Munkarah · Henry Ford Health System1 papers (2015–2015)Deepak Nagrath · University of Michigan1 papers (2022–2022)Lora H. Ellenson · Memorial Sloan Kettering Cancer Center1 papers (2018–2018)Jason R. Spence · University of Michigan1 papers (2017–2017)Brooke E. Howitt · Cancer Institute (WIA)1 papers (2018–2018)Bojana Djordevic · Sunnybrook Health Science Centre1 papers (2018–2018)Nisha Nagarsheth · National Cancer Institute1 papers (2015–2015)Ajjai Alva · University of Colorado Anschutz Medical Campus1 papers (2014–2014)